Ligand · JMI
JMI · ~{N}-[2-[4-[(2~{R},3~{S},4~{S},5~{S},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxyphenyl]ethyl]ethanamide
JMI, ~{N}-[2-[4-[(2~{R},3~{S},4~{S},5~{S},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxyphenyl]ethyl]ethanamide (C16 H23 N O7, 341.4 g/mol), in the MolNFT structures on GenesisL1: bound in 1 record (1 PDB entry). Every binding…
- Component
- JMI
- Formula
- C16 H23 N O7
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
JMI in 1 structure; the first of them:
- 7YTQ · Human langerin carbohydrate recognition domain in complex with an alpha-mannoside ligand · JMI A402 · binds GLU285, ASN287, ALA289, GLU293, LYS299, ASN307, ASP308
Residues it binds most
ASN 4, GLU 4, ALA 4, ASP 4, LYS 4 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.